per lonning

per lonning

University of Bergen, Norway
Verified email at helse-bergen.no
Cited by 67836
Breast Cancer Endocrine therapy chemoresistance germline risk factors
Marcus Schmidt

Marcus Schmidt

Professor of Molecular Oncology, University Medical Center Mainz
Verified email at unimedizin-mainz.de
Cited by 20609
Breast cancer prognostic and predictive factors biomarker immunotherapy endocrine therapy
Anita Dunbier

Anita Dunbier

University of Otago
Verified email at otago.ac.nz
Cited by 4971
Breast cancer research Molecular oncology Endocrine therapy Genomics
Svetlana Semina

Svetlana Semina

Research Assistant Professor, UIC
Verified email at uic.edu
Cited by 988
single cell RNA sequencing breast cancer endocrine therapy
Sreeja Sreekumar

Sreeja Sreekumar

Principal Scientist, Cardiff Oncology
Cited by 815
Antibody drug conjugates Breast cancer Estrogen Receptor Endocrine therapy
Dina Hany

Dina Hany

Département de Biologie Moléculaire et Cellulaire, Université de Genève, Sciences III, 1211 …
Verified email at unige.ch
Cited by 54
Breast cancer Drug resistance Tamoxifen Endocrine therapy Endocrine resistance